Margit Janat-Amsbury, MD, PhD

Chief Medical Officer
Halia Therapeutics
Salt Lake City, Utah

Disclosure information not submitted.

Presentation(s):

• Characterization of the NLRP3 Inflammasome Inhibitor HT-6184 in the Complete Freund's Adjuvant (CFA)-Induced Pain Model

  POSTER ABSTRACT